Mind Medicine Inc
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials… Read more
Mind Medicine Inc (MNMD) - Total Liabilities
Latest total liabilities as of September 2025: $106.32 Million USD
Based on the latest financial reports, Mind Medicine Inc (MNMD) has total liabilities worth $106.32 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mind Medicine Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how Mind Medicine Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mind Medicine Inc Competitors by Total Liabilities
The table below lists competitors of Mind Medicine Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sineng Electric Co Ltd
SHE:300827
|
China | CN¥6.53 Billion |
|
Sichuan Tuopai Shede Wine Co Ltd
SHG:600702
|
China | CN¥5.15 Billion |
|
Youngy Co Ltd
SHE:002192
|
China | CN¥981.19 Million |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | ₹13.57 Billion |
|
FRANKS INTL N.V. EO -01
F:FK2
|
Germany | €788.08 Million |
|
Asmedia Technology Inc
TW:5269
|
Taiwan | NT$3.47 Billion |
|
Torm PLC Class A
NASDAQ:TRMD
|
USA | $1.04 Billion |
|
Nanjing ESTUN Automation Co Ltd
SHE:002747
|
China | CN¥8.21 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Mind Medicine Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mind Medicine Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mind Medicine Inc (2015–2024)
The table below shows the annual total liabilities of Mind Medicine Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $60.70 Million | +30.81% |
| 2023-12-31 | $46.41 Million | +143.27% |
| 2022-12-31 | $19.08 Million | +54.61% |
| 2021-12-31 | $12.34 Million | +118.33% |
| 2020-12-31 | $5.65 Million | +2740.31% |
| 2019-12-31 | $198.96K | +2317.58% |
| 2018-12-31 | $8.23K | -89.77% |
| 2017-12-31 | $80.44K | +6.59% |
| 2016-12-31 | $75.47K | +908.28% |
| 2015-12-31 | $7.49K | -- |